BFC Planning’s OS Therapies Inc OSTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.4K Hold
1,500
– – ﹤0.01% 2959
2026
Q2
$2.85K Buy
1,500
+200
+15% +$335 ﹤0.01% 2890
2026
Q1
$1.83K Hold
1,300
– – ﹤0.01% 2615
2025
Q4
$1.82K Hold
1,300
– – ﹤0.01% 2658
2025
Q3
$2.55K Hold
1,300
– – ﹤0.01% 2409
2025
Q2
$2.44K Buy
1,300
+500
+63% +$842 ﹤0.01% 2259
2025
Q1
$1.23K Buy
800
+118
+17% +$277 ﹤0.01% 2413
2024
Q4
$2.92K Buy
682
+182
+36% +$533 ﹤0.01% 2183
2024
Q3
$1.4K Buy
+500
New +$1.79K ﹤0.01% 2350

Other funds holding OSTX

BFC Planning's OSTX Position: Q3 2026 in Review

BFC Planning held its OS Therapies Inc (OSTX) position steady in Q3 2026 at 1,500 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2959.

BFC Planning first reported a position in OSTX in Q3 2024 and has held it in 9 quarters since. The position peaked at $2.92K in Q4 2024. 25 funds tracked by Wall St. Rank hold OSTX as of Q3 2026.

  • BFC Planning held 1,500 shares of OS Therapies Inc worth $2.4K as of Q3 2026.
  • BFC Planning left its OS Therapies Inc share count unchanged in Q3 2026.
  • OS Therapies Inc made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2959 holding.
  • BFC Planning first reported a position in OS Therapies Inc in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's OS Therapies Inc position peaked at $2.92K in Q4 2024.
  • 25 funds tracked by Wall St. Rank held OS Therapies Inc as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.